home > pmps > winter 2012 > the ultimate aim
Pharmaceutical Manufacturing and Packing Sourcer

The Ultimate Aim

Working to improve the execution of global temperature-controlled transport operations, the Cool Chain Association is continuing to search for best practice solutions and a cleaner, seamless perishable goods supply chain for the benefi t of its members and, ultimately, patients worldwide. By 2050 there will be more than nine billion people on the planet. Taking into account the inevitable economic shift that will occur as emerging economies mature and global wealth increases, this implies that the world will need to produce 70 per cent more food and healthcare produce than today. We are already facing di culties feeding the world population, and according to a study by the UN, one third of perishables – equalling 1.3 billion tones per year – is lost or wasted globally, mainly due to problems in the supply chain. Balancing supply shortage and surplus will be the challenge in the future. This can only be achieved through closer cooperation in the supply chain.

As life expectancies increase, the demand for pharmaceutical products is also likely to rise. Given the fact that global social healthcare systems are increasingly unsustainable due to rising costs, there is more pressure on the supply chain to deliver a cost-efficient service that consistently maintains the highest quality standards.

The goal of the Cool Chain Association (CCA), established in 2003, is to bring together all parties in the supply chain to facilitate vertical and horizontal cooperation to reduce global hunger and improve the quality of temperaturesensitive products.

The CCA is committed to several goals. Delivery of concrete contributions to improve the cool chain is essential. Improving quality in the temperaturesensitive supply chain will reduce food wastage and food-borne illnesses, contributing to improving overall health and reducing global hunger.

Reducing carbon emissions and fostering collaboration will make the cool chain more sustainable. Investing in innovation, research and education is a key requirement for both the short and the long term. Billions of dollars are at risk as perishables move through the global chain, so the stakes are high.

In 10 years time the CCA aims to become a global organisation, and the initiatives it has taken to help improve awareness of issues in the cool chain will hopefully turn out to be instrumental to improved performance. Ultimately, the organisation and its members will have contributed to a better, safer, healthier and more sustainable world.

It is the CCA’s mission to improve the quality, efficiency and value of the temperature-sensitive supply chain by enabling collaboration, education and innovation amongst members and stakeholders.

By 2020 the CCA and its members aim to have had a visible impact in improving the quality of perishables, and improving sustainability, amongst other targets. The organisation has therefore identified relevant focus areas to maximise the social, environmental and economic effects of its initiatives, innovations and projects. The CCA is also committed to ‘healthy living’ and is focusing on initiatives across three areas: access to information, mobility and transport, and innovation.

Healthy Living

Good health is fundamental to personal wellbeing and the quality of society. Variations in temperature or humidity can render modern medical miracles useless and pose threats to the perishables people consume. The CCA is committed to providing a knowledge centre to explore ways to reduce wastage and food born diseases, improve shelf-life, fight counterfeiting and improve traceability.

Access to Information

A new information infrastructure is emerging where people and tools will communicate with each other in new ways and employ open data. The innovating power of the internet enables us to do things differently: more efficiently, better, faster, smarter and more sustainably. The CCA is committed to improve involvement and competence by helping to:
  •  Create trust by improving transparency
  •  Make new technologies practicable
  •  Stimulate new software solutions
  •  Monitor shipments
  •  Share information more easily

Mobility and Transport

Mobility and transport are conditions for prosperity and welfare, but currently available mobility systems are also harmful to the economy, people and the environment. Half-full trucks, increasing energy usage, emission of CO2, redistributing returnable transport items – all these issues force us to restructure our mobility patterns. The CCA hopes to increase awareness and stimulate all stakeholders to:
  •  Invest in clean mobility
  •  Promote sustainable equipment
  •  Reduce inefficiencies
  •  Improve reliability of logistics
  •  Improve RTIs and packaging


Finding solutions to cool chain challenges demands technological innovation across the chain, from factory to pharmacy, across products, assets and processes. This requires in-depth understanding of the issues to enable efforts to focus on key areas. The CCA is committed to facilitating this by helping to bring different stakeholders together, provide a platform for information sharing, showcase successful innovations, stimulate and focus new innovations, and interact with universities and R&D.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

The Cool Chain Association is a non-profit organisation, founded in 2003, with the aim of synchronising the cool supply chain to improve the quality of perishables and temperature sensitive products (PTSP), prolong their shelf life and reduce wastage. CCA and GL-Certification (GLC) have recently developed the Cool Chain Quality Indicators (CCQI), which provide a standard to enable retailers and brand-owners to find a suitable supply chain provider.
The Cool Chain Association
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Running Smarter Trials With Data-Driven Monitoring


Clinical monitoring remains one of the most important and most costly activities in the clinical research paradigm.  Monitoring provides the operational transparency required by investigators, sponsors, and regulators to make informed decisions about site performance, patient safety, and overall study progress. Yet unlike many clinical trial activities, which have been steadily transformed by technology, the monitoring function itself has changed little.
More info >>

Industry Events



SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement